부산대학교 도서관

Parker, Christopher C ; Clarke, Noel W ; Cook, Adrian D ; Kynaston, Howard G ; Petersen, Peter Meidahl ; Catton, Charles ; Cross, William ; Logue, John ; Parulekar, Wendy ; Payne, Heather ; Persad, Rajendra ; Pickering, Holly ; Saad, Fred ; Anderson, Juliette ; Bahl, Amit ; Bottomley, David ; Brasso, Klaus ; Chahal, Rohit ; Cooke, Peter W ; Eddy, Ben ; Gibbs, Stephanie ; Goh, Chee ; Gujral, Sandeep ; Heath, Catherine ; Henderson, Alastair ; Jaganathan, Ramasamy ; Jakobsen, Henrik ; James, Nicholas D ; Kanaga Sundaram, Subramanian ; Lees, Kathryn ; Lester, Jason ; Lindberg, Henriette ; Money-Kyrle, Julian ; Morris, Stephen ; O'Sullivan, Joe ; Ostler, Peter ; Owen, Lisa ; Patel, Prashant ; Pope, Alvan ; Popert, Richard ; Raman, Rakesh ; Røder, Martin Andreas ; Sayers, Ian ; Simms, Matthew ; Wilson, Jim ; Zarkar, Anjali ; Parmar, Mahesh K B ; Sydes, Matthew R

In The Lancet 31 October-6 November 2020 396(10260):1413-1421

Zarkar A; Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.; Pirrie S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom. Electronic address: s.j.pirrie@bham.ac.uk.; Stubbs C; Birmingham Clinical Trials Unit (BCTU), University of Birmingham, Birmingham, United Kingdom.; Hodgkins AM; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom.; Farrugia D; Cheltenham General Hospital, Cheltenham, United Kingdom.; Fife K; Addenbrooke's Hospital, Cambridge, United Kingdom.; MacDonald-Smith C; Glan Clwyd Hospital, Rhyl, United Kingdom.; Vasudev N; St James's University Hospital, Leeds, United Kingdom.; Porfiri E; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom; Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE

Parker CC; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: chris.parker@rmh.nhs.uk.; Petersen PM; Department of Oncology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester; Manchester Cancer Research Centre, The University of Manchester, Manchester; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK, Department of Urology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Catton C; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds.; Kynaston H; Division of Cancer and Genetics, Cardiff University, Cardiff, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, Canada.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada.; Bower L; Guy's and St Thomas' NHS Foundation Trust, London; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK.; Durkan GC; Department of Urology, University Hospital Galway, Galway, Ireland.; Logue J; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester.; Maniatis C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Noor D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Payne H; The Prostate Centre, London.; Anderson J; St James's Institute of Oncology, Leeds.; Bahl AK; Bristol Haematology and Oncology Centre, University Hospitals Bristol & Weston NHS Trust, Bristol.; Bashir F; Queen's Centre for Oncology, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK.; Bottomley DM; St James's Institute of Oncology, Leeds.; Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Capaldi L; Worcester Oncology Centre, Worcestershire Acute NHS Hospitals Trust, Worcester.; Chung C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Cooke PW; Department of Urology, The Royal Wolverhampton NHS Trust, Wolverhampton.; Donohue JF; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone.; Eddy B; East Kent University Hospitals Foundation Trust, Kent.; Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton.; Henderson A; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone.; Henry A; Leeds Institute of Medical Research, University of Leeds, Leeds.; Jaganathan R; Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Jakobsen H; Department of Urology, Herlev University Hospital, Herlev, Denmark.; James ND; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK.; Joseph J; Leeds Teaching Hospitals; York and Scarborough Teaching Hospitals, York.; Lees K; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone.; Lester J; South West Wales Cancer Centre, Singleton Hospital, Swansea, UK.; Lindberg H; Department of Oncology, Herlev University Hospital, Herlev, Denmark.; Makar A; Department of Urology, Worcestershire Acute Hospitals Trust, Worcester.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London.; Oommen N; Wrexham Maelor Hospital, Wrexham.; Ostler P; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London.; Owen L; Bradford Royal Infirmary, Bradford; Leeds Cancer Centre, Leeds.; Patel P; Department of Urology, University College London Hospitals, London.; Pope A; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London.; Popert R; Guy's and St Thomas' NHS Foundation Trust, London.; Raman R; Kent Oncology Centre, Kent & Canterbury Hospital, Canterbury.; Ramani V; Department of Urology, The Christie NHS Foundation Trust, Manchester.; Røder A; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen.; Sayers I; Deanesly Centre, New Cross Hospital, Wolverhampton.; Simms M; Department of Urology, Hull University Hospitals NHS Trust, Hull.; Srinivasan V; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl.; Sundaram S; Department of Urology, Mid Yorkshire Teaching Hospital, Wakefield.; Tarver KL; Department of Oncology, Queen's Hospital, Romford.; Tran A; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester.; Wells P; Barts Cancer Centre, St Bartholomews Hospital, London.; Wilson J; Royal Gwent Hospital, Newport.; Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Parker CC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Urology, Salford Royal Hospital, Salford, UK.; Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Kynaston H; Division of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.; Catton CN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Cross WR; Department of Urology, St James's University Hospital, Leeds, UK.; Petersen PM; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK.; Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bower LC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Logue J; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Payne H; The Prostate Centre, London, UK.; Forcat S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Goldstein C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Murphy C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Anderson J; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Barkati M; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.; Bottomley DM; Department of Clinical Oncology, St James's University Hospital, Leeds, UK.; Branagan J; Northampton General Hospital, Northampton, UK.; Choudhury A; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Chung PWM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; Cogley L; Derriford Hospital, Plymouth, UK.; Goh CL; Royal Surrey Hospital, Guildford, UK.; Hoskin P; Division of Cancer Sciences, University of Manchester, Manchester, UK; Mount Vernon Cancer Centre, Northwood, UK.; Khoo V; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Malone SC; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.; Masters L; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Morris SL; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Nabid A; Service de Radio-Oncologie, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.; Ong AD; Max Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; Raman R; Kent Oncology Centre, Kent and Canterbury Hospital, Canterbury, UK.; Tarver KL; Department of Oncology, Queen's Hospital, Romford, UK.; Tree AC; The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK.; Worlding J; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Wylie JP; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK.; Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.; Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.; Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: mrcctu.radicals@ucl.ac.uk.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE